Navigation Links
Avanir Pharmaceuticals Reports Fiscal 2012 Third Quarter Financial And Business Results
Date:8/8/2012

ALISO VIEJO, Calif., Aug. 8, 2012 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today reported financial results for the three and nine months ended June 30, 2012.

Quarterly Financial Highlights

  • Gross and net NUEDEXTA® sales of $12.2 million and $10.1 million, respectively
  • Total company net revenues of $10.5 million
  • Cash, cash equivalents, and restricted investments of $84.1 million as of June 30, 2012

    • "Our fiscal third quarter results reflect another significant increase in net sales of NUEDEXTA seen in both our retail and institutional business," said Keith A. Katkin, president and CEO of Avanir. "Going forward, our commercial team will continue to drive revenue growth by increasing recognition of pseudobulbar affect and awareness of NUEDEXTA as the only FDA-approved treatment."

    Fiscal 2012 Third Quarter Results

  • Total net revenues for the quarter ended June 30, 2012 were $10.5 million, compared with $2.5 million for the comparable quarter in 2011. Total net revenues consist of NUEDEXTA revenue and royalty revenue from Abreva®.
  • Total operating expenses were $24.7 million in the third quarter of fiscal 2012, compared with $18.4 million in the comparable period in fiscal 2011.
  • Cash used in operations was $14.9 million in the third quarter of fiscal 2012.
  • Net loss for the fiscal 2012 third quarter was $15.0 million, or $0.11 per share, compared with a net loss of $16.1 million, or $0.13 per share, for the same period in fiscal 2011.

    • Nine-Month Results

  • Total net revenues for the first nine-months of fiscal 2012 totaled $27.7 million, compared with $5.7 million for the first nine-months of fiscal 2011.
  • Total operating expenses were $74.1 million in the first nine-months of fiscal 2012, compared to $48.1 million in the comparable period for fi
    '/>"/>

    • SOURCE Avanir Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6 7

    Related biology technology :

    1. Avanir Pharmaceuticals to Participate in Citi 2012 Global Health Care Conference
    2. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
    3. Convergence Pharmaceuticals Initiates Phase I Multiple Ascending Dose Study for CNV2197944
    4. TetraLogic Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of TL32711 in Patients with Acute Myelogenous Leukemia (AML)
    5. Questcor Pharmaceuticals to Present at the Oppenheimer Healthcare Conference on December 13, 2011
    6. Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie
    7. Acumen Pharmaceuticals Regains Worldwide Rights to Anti-ADDL Antibody Therapeutics and Diagnostics for Alzheimers Disease From Merck
    8. Inspiration Biopharmaceuticals Moves Corporate Headquarters to Cambridge, Massachusetts
    9. Ampio Pharmaceuticals Awarded Canadian Composition of Matter Patent That Strengthens IP Protection for Its Key Drug Ampion™
    10. Amylin Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
    11. Inovio Pharmaceuticals Promotes Niranjan Sardesai to Chief Operating Officer
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/18/2013)... 18, 2013 The Pistoia ... the HELM biomolecular representation standard software toolkit and ... HELM (Hierarchical Editing Language for Macromolecules) ... biomolecules (e.g. proteins, nucleotides, antibody drug conjugates) whose ... informatics methodologies impractical or unusable. HELM solves this ...
    (Date:6/18/2013)... , June 18, 2013 ... international investment research firm, announces the initiation ... a French biopharmaceutical company developing and marketing ... care indications.      (Logo: http://photos.prnewswire.com/prnh/20130417/608168) ... comprehensive report examining the investment merits of ...
    (Date:6/18/2013)... -- The "Bioinformatics Market By Sector (Molecular Medicine, Agriculture, ... Data Analysis Services) & Application (Genomics, Proteomics & Drug Design) - Global ... Restraints, and Opportunities in North America , ... and Rest of World. Browse , ... Figures 364 Pages and an in-depth ...
    (Date:6/18/2013)... , June 18, 2013  Techne Corporation (NASDAQ: ... it has agreed to acquire 100% ownership of ... Inc. (Bionostics).  Bionostics is a global leader in ... that verify the proper operation of in ... point of care blood glucose and blood gas ...
    Breaking Biology Technology:The Pistoia Alliance Releases HELM Biomolecular Representation Standard Open Source Tools 2Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 2Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 3Bioinformatics Market Worth $7.5 Billion by 2017 2Bioinformatics Market Worth $7.5 Billion by 2017 3Techne Corporation Announces Acquisition Agreement 2Techne Corporation Announces Acquisition Agreement 3Techne Corporation Announces Acquisition Agreement 4Techne Corporation Announces Acquisition Agreement 5
    ... YORK , July 7 Reportlinker.com announces that a new market ... , , ... , , , ... , , ...
    ... July 9, 2010 Federico Capasso, Robert L. Wallace ... Fellow in Electrical Engineering at the Harvard School of ... 2010 Berthold Leibinger Zukunftspreis (the future prize), an international ... of laser light. The prize, consisting of 30,000, ...
    ... July 6 /PRNewswire/ - Ocean Nutrition Canada Limited - Long time ... make way for a new CEO to lead the company,s next growth phase, ... , , ... food industry veteran, has been appointed as the new President and CEO at ...
    Cached Biology Technology:Building Biotech Technology Transfer Opportunities: Sponsor and Developer Strategies for Success 2Building Biotech Technology Transfer Opportunities: Sponsor and Developer Strategies for Success 3Building Biotech Technology Transfer Opportunities: Sponsor and Developer Strategies for Success 4Building Biotech Technology Transfer Opportunities: Sponsor and Developer Strategies for Success 5Building Biotech Technology Transfer Opportunities: Sponsor and Developer Strategies for Success 6Building Biotech Technology Transfer Opportunities: Sponsor and Developer Strategies for Success 7Building Biotech Technology Transfer Opportunities: Sponsor and Developer Strategies for Success 8Building Biotech Technology Transfer Opportunities: Sponsor and Developer Strategies for Success 9Building Biotech Technology Transfer Opportunities: Sponsor and Developer Strategies for Success 10Laser pioneer Federico Capasso awarded Berthold Leibinger Zukunftspreis 2New President and CEO appointed at Ocean Nutrition Canada Limited 2New President and CEO appointed at Ocean Nutrition Canada Limited 3
    (Date:6/19/2013)... across the Midwest are expected to contribute to a ... "dead zone," according to a University of Michigan ecologist ... with one for the Chesapeake Bay. , The Gulf ... and Atmospheric Administration, calls for an oxygen-depleted, or hypoxic, ... would place it among the 10 largest on record. ...
    (Date:6/18/2013)... June 19, 2013  Paris Air Show – ... Test Systems) , a leading provider of innovative ... is demonstrating its solutions this week at the ... With growing challenges including increasingly complex armament systems ... feature-rich, specialized aerospace test solutions that address legacy ...
    (Date:6/18/2013)... UT Arlington environmental engineer has been awarded a ... to ensure water quality and flow in the ... , Andrew Kruzic, UT Arlington associate professor of ... locations to add monochloramine to the water in ... new pump stations and pipelines. Adding monochloramine is ...
    Breaking Biology News(10 mins):U-M researcher and colleagues predict possible record-setting Gulf of Mexico 'dead zone' 2U-M researcher and colleagues predict possible record-setting Gulf of Mexico 'dead zone' 3U-M researcher and colleagues predict possible record-setting Gulf of Mexico 'dead zone' 4Marvin Test Solutions Demonstrates Next-Generation Armament Test Solutions at Paris Air Show 2Marvin Test Solutions Demonstrates Next-Generation Armament Test Solutions at Paris Air Show 3UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline 2
    ... blood test may help doctors better predict whether prostate cancer ... for the disease, researchers at UT Southwestern Medical Center have ... issue of Clinical Cancer Research , UT Southwestern scientists ... 86 percent accuracy which prostate cancer patients will experience a ...
    ... at the Smithsonian,s National Zoo have performed the ... ( E. ferus przewalskii ; E. caballus ... are a horse species native to China and ... in 1970. Currently, there are approximately 1500 of ...
    ... the human gene DRD4 is linked to better health ... settled cousins, according to new research by a team ... (UWM). A study by UWM assistant professor Ben ... UNLV shows that a particular version of the gene ...
    Cached Biology News:Urologists identify 7 biomarkers that may help pinpoint prostate cancer recurrence 2First successful reverse vasectomy on endangered species performed at the National Zoo 2First successful reverse vasectomy on endangered species performed at the National Zoo 3Did the gene for ADHD help our nomadic ancestors? 2
    ... is a small and sensitive single ... both LC and IC. It features a ... Ionization (API) source for outstanding sensitivity and ... with existing LC and IC methods, especially ...
    Kit for BASE20/50 dual control unit, includes mounting plate, HOLDER50T, HEATERPAD50, SRTDX temperature probe(s)....
    ...
    ... R&D Systems Cell and Tissue Staining Kits ... a broad range of histological and cytological ... primary IgG antibodies manufactured by either R&D ... is based on the formation of the ...
    Biology Products: